Experimental induction of reduced ovarian reserve in a nonhuman primate model (Macaca fascicularis).
Chronic diseases including coronary heart disease and osteoporosis represent a substantial health burden to postmenopausal women, yet the initiation of these conditions and their relationships with reproductive aging remain poorly understood. This situation is due, in part, to the lack of animal models reflecting ovarian and hormonal characteristics of peri- and postmenopausal women. Ovaries of women approaching menopause are nearly depleted of primordial follicles but retain a pool of larger developing follicles and androgen-producing stroma, a condition known as reduced ovarian reserve (ROR). The long-term goal of the research presented here was to create a monkey model of reproductive aging, beginning with ROR and progressing to perimenopause and finally postmenopause. Here we sought to develop a method to reduce primordial follicles in cynomolgus monkeys (Macaca fascicularis) and document hormonal changes associated with follicle reduction or ROR. At 30 d after surgical placement of a biodegradable fiber containing approximately 200 mg of 4-vinlycyclohexene diepoxide (VCD) next to one ovary in each of 8 monkeys, primordial follicles were reduced by approximately 70%, with a corresponding decrease (83%) in antimüllerian hormone (AMH, a serum marker of ovarian follicle numbers). At 4 mo after VCD-treatment of both ovaries in 29 monkeys (approximately 200 mg VCD per ovary), AMH was reduced 56% from baseline, testosterone was unchanged, and follicular phase estradiol was slightly increased. These data indicate that VCD treatment markedly reduced primordial follicles while preserving larger estradiol- and testosterone-producing follicles and ovarian stroma, a condition that mimics ROR in women.
Department of Pathology (Comparative Medicine), Wake Forest University Primate Center, Winston-Salem, North Carolina, USA. sappt@wfubmc.edu
Susan E
SE
Appt
Thomas B
TB
Clarkson
Patricia B
PB
Hoyer
Nancy D
ND
Kock
Amanda K
AK
Goode
M Christina
MC
May
Joseph T
JT
Persyn
Neal K
NK
Vail
Kelly F
KF
Ethun
Haiying
H
Chen
Nivedita
N
Sen
Jay R
JR
Kaplan
D000818:Animals; D054304:Anti-Mullerian Hormone / Q000097:blood; D053138:Cyclohexenes; D004195:Disease Models, Animal; D005260:Female; D008252:Macaca fascicularis; D010049:Ovarian Diseases / Q000139:chemically induced*; D006080:Ovarian Follicle / Q000187:drug effects* / Q000473:pathology; D010053:Ovary / Q000187:drug effects / Q000473:pathology; D046468:Sexual Development / Q000187:drug effects*; D014753:Vinyl Compounds
D053138:Cyclohexenes; D014753:Vinyl Compounds; C012606:4-vinyl-1-cyclohexene dioxide; D054304:Anti-Mullerian Hormone
Toxicol Pathol. 2001 Jan-Feb;29(1):91-9
11215690
Am J Clin Nutr. 2007 Jul;86(1):245-50
17616787
J Clin Endocrinol Metab. 2007 Aug;92(8):3060-7
17550960
J Clin Endocrinol Metab. 2008 Sep;93(9):3478-83
18593767
Arteriosclerosis. 1985 Mar-Apr;5(2):192-200
3977777
J Reprod Med. 2001 Mar;46(3 Suppl):307-15
11310451
Reprod Toxicol. 2008 Oct;26(2):116-22
18706995
Maturitas. 2010 Sep;67(1):7-14
20430541
J Clin Endocrinol Metab. 2001 Jan;86(1):41-7
11231976
Hum Reprod. 2006 Aug;21(8):2022-6
16679324
Fertil Steril. 2006 May;85(5):1425-31
16600235
Metabolism. 2008 Jul;57(7 Suppl 1):S24-31
18555850
Arterioscler Thromb Vasc Biol. 1995 Dec;15(12):2094-100
7489229
Reproduction. 2006 Sep;132(3):443-53
16940285
Reprod Toxicol. 1996 Mar-Apr;10(2):137-43
8919611
Xenotransplantation. 2005 Jan;12(1):72-5
15598276
Hum Reprod Update. 2007 Nov-Dec;13(6):559-65
17630397
J Clin Endocrinol Metab. 1994 Mar;78(3):615-21
8126132
J Clin Endocrinol Metab. 2001 Nov;86(11):5396-404
11701713
Fertil Steril. 2006 Oct;86(4 Suppl):1210-6
16952357
J Clin Endocrinol Metab. 2008 Jun;93(6):2129-34
18334591
ILAR J. 2006;47(3):259-71
16804200
Fertil Steril. 2008 Aug;90(2):395-400
17919608
Menopause. 2008 Nov-Dec;15(6):1139-44
18779761
Endocrinology. 2007 May;148(5):2273-81
17317775
Adv Exp Med Biol. 2001;500:73-81
11765019
J Clin Endocrinol Metab. 2006 Oct;91(10):4057-63
16804046
Biol Reprod. 2003 Jan;68(1):10-8
12493689
Biol Reprod. 2001 Jul;65(1):87-93
11420227
Menopause. 2008 Sep-Oct;15(5):950-7
18427358
Hum Reprod. 2006 Dec;21(12):3103-7
16923748
Obstet Gynecol. 2002 Mar;99(3):381-8
11864663
Fertil Steril. 2008 Apr;89(4):1034-5
18325504
BJOG. 2004 Nov;111(11):1248-53
15521870
Menopause. 2004 Jan-Feb;11(1):120-30
14716193
Menopause. 2008 Nov-Dec;15(6):1086-94
18791485
Psychosom Med. 1996 Nov-Dec;58(6):598-611
8948008
J Clin Endocrinol Metab. 2004 Jun;89(6):2998-3006
15181090
Mol Cell Endocrinol. 2005 Apr 29;234(1-2):81-6
15836956
Reprod Toxicol. 1999 Jan-Feb;13(1):67-75
10080302
Birth Defects Res B Dev Reprod Toxicol. 2007 Apr;80(2):113-25
17342769
Reproduction. 2006 Jan;131(1):1-9
16388003
Toxicol Appl Pharmacol. 1996 Aug;139(2):394-401
8806857
J Reprod Fertil. 1968 Dec;17(3):555-7
5715685
Menopause. 2002 Sep-Oct;9(5):320-8
12218720
Atherosclerosis. 2008 Jan;196(1):106-113
17367795
Menopause. 2004 Nov-Dec;11(6 Pt 1):601-6
15545787
Menopause. 2009 May-Jun;16(3):597-601
19188851
Menopause. 2008 Jul-Aug;15(4 Pt 1):603-12
18574431
Fertil Steril. 2006 Apr;85 Suppl 1:1179-86
16616090
Mol Cell Biol. 2006 Feb;26(3):940-54
16428448
Am J Primatol. 2009 Sep;71(9):766-75
19530126